🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
This is a phase 2 single-arm, open-label clinical trial determining efficac...
Status
Active Not Recruiting
Location
University of California, Los Angeles
Start Date
2020-02-19
Trial ID
NCT04231851
Study of the efficacy of CPX-351 treatment in patients with higher risk mye...
Status
Completed
Location
CHU d'Amiens - Service d'hématologie clinique et thérapie cellulaire
Start Date
2020-04-29
Trial ID
NCT04273802
Treatments Being Tested
To search for a Maximum Tolerated Dose (MTD) for the combination of daratum...
Status
Recruiting
Location
CHU de Nantes
Start Date
2025-02-06
Trial ID
NCT05749276
Treatments Being Tested
To confirm the efficacy of CPX-351 compared to 7+3 as first line therapy in...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2012-12-13
Trial ID
NCT01696084
Treatments Being Tested
This phase II trial studies the side effects and how well Vyxeos works in t...
Status
Recruiting
Location
UC Davis Comprehensive Cancer Center
Start Date
2021-01-29
Trial ID
NCT04049539
Treatments Being Tested
The three classic myeloproliferative neoplasms (MPNs) include polycythemia ...
Status
Completed
Location
AMIENS - CHU Amiens Picardie
Start Date
2022-03-23
Trial ID
NCT04992949
Treatments Being Tested
This is a Phase I/II study evaluating safety and efficacy of proteasome inh...
Status
Recruiting
Location
Masonic Cancer Center
Start Date
2025-07-07
Trial ID
NCT07008638
Treatments Being Tested
Treatment with intensive chemotherapy in AML results in approximately 70% s...
Status
Recruiting
Location
St. Anna Kinderspital
Start Date
2020-11-06
Trial ID
NCT07156435
Treatments Being Tested
Approximately 10% of patient develop AML after chemotherapy or radiation fo...
Status
Completed
Location
CHU de Nice
Start Date
2024-10-11
Trial ID
NCT06349239
Treatments Being Tested